Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfizer Inc (NYSE:PFE)

35.11
Delayed Data
As of Aug 29
 +0.29 / +0.83%
Today’s Change
28.25
Today|||52-Week Range
37.39
+8.77%
Year-to-Date
Gilead Was Smart to Let Medivation Slip Through its Fingers
Aug 29 / GuruFocus News - Paid Partner Content
Pharmaceuticals are the New Bonds
Aug 26 / GuruFocus News - Paid Partner Content
Mylan to launch cut-price generic version of EpiPen
Aug 29 / FT.com - Paid Partner Content
Can Novartis Tide Over the Alcon Crisis?
Aug 26 / GuruFocus News - Paid Partner Content
Sanofi's Risk Increases on Acquisition Miss
Aug 28 / GuruFocus News - Paid Partner Content
Dow 30 Stock Roundup: Pfizer's Big Buy, Boeing's Big Win
Aug 26 / Zacks.com - Paid Partner Content
3 Stocks Up Over 1,000% in the Past 5 Years
Aug 28 / MotleyFool.com - Paid Partner Content
3 Top Stocks For Retirees
Aug 26 / MotleyFool.com - Paid Partner Content
The EpiPen Scandal Is Worse Than You Think: What Youre Not Being Told
Aug 27 / Investing Channel - Paid Partner Content
Game On for Pfizer With $14 Billion Medivation Buyout (or, Why Pfizer's Buyout of Med...
Aug 26 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close34.82
Today’s open34.94
Day’s range34.82 - 35.17
Volume15,124,885
Average volume (3 months)24,055,278
Market cap$211.2B
Dividend yield3.42%
Data as of 08/29/2016

Growth & Valuation

Earnings growth (last year)-21.24%
Earnings growth (this year)+11.84%
Earnings growth (next 5 years)+6.90%
Revenue growth (last year)-1.52%
P/E ratio31.1
Price/Sales4.13
Price/Book3.32

Competitors

 Today’s
change
Today’s
% change
NVSNovartis+0.33+0.42%
MRKMerck+0.16+0.25%
AGNPRAAllergan plc-10.23-1.20%
GSKGlaxoSmithKline+0.06+0.14%
Data as of 08/29/2016

Financials

Next reporting dateOctober 25, 2016
EPS forecast (this quarter)$0.62
Annual revenue (last year)$48.9B
Annual profit (last year)$7.0B
Net profit margin14.22%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Ian C. Read
Chief Financial Officer &
EVP-Business Operations
Frank A. D'Amelio
Corporate headquarters
New York, New York

Forecasts

Partner Offers

Search for Jobs